Beyond conventional antibiotics - New directions for combination products to combat biofilm

被引:56
作者
Bayramov, Danir Fanisovich [1 ]
Neff, Jennifer Ann [1 ]
机构
[1] Allvivo Vasc Inc, 20914 Bake Pkwy,Suite 100, Lake Forest, CA 92630 USA
基金
美国国家卫生研究院;
关键词
Antimicrobial; Antimicrobial peptides; Antibiotic resistance; Compartment model; Local drug delivery; Medical device coatings; CATIONIC ANTIMICROBIAL PEPTIDES; CENTRAL VENOUS CATHETERS; HOST-DEFENSE PEPTIDES; BLOOD-STREAM INFECTIONS; PSEUDOMONAS-AERUGINOSA; IN-VITRO; STAPHYLOCOCCUS-AUREUS; MICROBIAL BIOFILMS; RESISTANCE MECHANISMS; GENTAMICIN-RELEASE;
D O I
10.1016/j.addr.2016.07.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Medical device related infections are a significant and growing source of morbidity and mortality. Biofilm formation is a common feature of medical device infections that is not effectively prevented or treated by systemic antibiotics. Antimicrobialmedical device combination products provide a pathway for local delivery of antimicrobial therapeutics with the ability to achieve high local concentrations while minimizing systemic side effects. In this review, we present considerations for the design of local antimicrobial delivery systems, which can be facilitated by modeling local pharmacokinetics in the context of the target device application. In addition to the need for local delivery, a critical barrier to progress in the field is the need to incorporate agents effective against bio-film. This article aims to review key properties of antimicrobial peptides that make them well suited to meet the demands of the next generation of antimicrobial medical devices, including broad spectrum activity, rapid and biocidal mechanisms of action, and efficacy against biofilm. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 60
页数:13
相关论文
共 194 条
  • [51] Prevention and control of biofilm-based medical-device-related infections
    Francolini, Iolanda
    Donelli, Gianfranco
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2010, 59 (03): : 227 - 238
  • [52] Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin
    French, G. L.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) : 1107 - 1117
  • [53] Survival strategies of infectious biofilms
    Fux, CA
    Costerton, JW
    Stewart, PS
    Stoodley, P
    [J]. TRENDS IN MICROBIOLOGY, 2005, 13 (01) : 34 - 40
  • [54] REACTION-MECHANISMS IN THE RADIOLYSIS OF PEPTIDES, POLYPEPTIDES, AND PROTEINS
    GARRISON, WM
    [J]. CHEMICAL REVIEWS, 1987, 87 (02) : 381 - 398
  • [55] The role of microbial biofilms in prosthetic joint infections
    Gbejuade, Herbert O.
    Lovering, Andrew M.
    Webb, Jason C.
    [J]. ACTA ORTHOPAEDICA, 2015, 86 (02) : 147 - 158
  • [56] Giangaspero A, 2001, EUR J BIOCHEM, V268, P5589
  • [57] The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity
    Gimenez, Diana
    Andreu, Cecilia
    del Olmo, Marcel-li
    Varea, Teresa
    Diaz, Dolores
    Asensio, Gregorio
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (20) : 6971 - 6978
  • [58] A controlled antibiotic release system to prevent orthopedic-implant associated infections: An in vitro study
    Gimeno, Marina
    Pinczowski, Pedro
    Perez, Marta
    Giorello, Antonella
    Angel Martinez, Miguel
    Santamaria, Jesus
    Arruebo, Manuel
    Lujan, Lluis
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 96 : 264 - 271
  • [59] The future of biologic coatings for orthopaedic implants
    Goodman, Stuart B.
    Yao, Zhenyu
    Keeney, Michael
    Yang, Fan
    [J]. BIOMATERIALS, 2013, 34 (13) : 3174 - 3183
  • [60] Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections
    Guggenbichler, Josef Peter
    Assadian, Ojan
    Boeswald, Michael
    Kramer, Axel
    [J]. GMS HYGIENE AND INFECTION CONTROL, 2011, 6 (01):